CIENCIASMEDICASNEWS: PubMed Clinical Queries

lunes, 22 de enero de 2018

PubMed Clinical Queries is an utility offered by PubMed to search scientific literature in specific clinical research areas

Search PubMed Clinical Queries for "Brca"

Results: 5 of 816

Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild-type BRCA pancreatic ductal adenocarcinoma.
O'Reilly EM, Lee JW, Lowery MA, Capanu M, Stadler ZK, Moore MJ, Dhani N, Kindler HL, Estrella H, Maynard H, et al.Cancer. 2018 Jan 16; . Epub 2018 Jan 16.
Impact of homologous recombination deficiency biomarkers on outcomes in patients with triple-negative breast cancer treated with doxorubicin-based adjuvant chemotherapy (SWOG S9313).
Sharma P, Barlow WE, Godwin AK, Pathak H, Isakova K, Williams D, Timms KM, Hartman AR, Wenstrup RJ, Linden HM, et al.Ann Oncol. 2017 Dec 23; . Epub 2017 Dec 23.
The OlympiAD trial: who won the gold?
Gyawali B.Ecancermedicalscience. 2017; 11:ed75. Epub 2017 Dec 6.
[Current German and American guidelines for autologous fat grafting - a transatlantic comparison].
Broelsch GF, Könneker S, Ipaktchi R, Vogt PM.Handchir Mikrochir Plast Chir. 2017 Dec; 49(6):408-414. Epub 2017 Dec 29.
Ovarian Cancer Prevention, Screening, and Early Detection: Report From the 11th Biennial Ovarian Cancer Research Symposium.
Chien J, Poole EM.Int J Gynecol Cancer. 2017 Nov; 27(9S Suppl 5):S20-S22.

See all (816)

This column displays citations filtered to a specific clinical study category and scope. These search filters were developed by Haynes RB et al. See more filter information.

Systematic Reviews

Results: 5 of 137

Cost-effectiveness and comparative effectiveness of cancer risk management strategies in BRCA1/2 mutation carriers: a systematic review.
Petelin L, Trainer AH, Mitchell G, Liew D, James PA.Genet Med. 2018 Jan 11; . Epub 2018 Jan 11.
Genetic Tests for Breast and Ovarian Cancer
Juvet LK, Natvig Norderhaug I.2008 Feb.
Variability in the therapeutic management of advanced ovarian cancer patients: a five-country survey of oncologists.
Audibert C, Perlaky A, Stuntz M, Glass D.Drug Des Devel Ther. 2017; 11:3471-3479. Epub 2017 Dec 6.
A comprehensive genomic meta-analysis identifies confirmatory role of <i>OBSCN</i> gene in breast tumorigenesis.
Rajendran BK, Deng CX.Oncotarget. 2017 Nov 24; 8(60):102263-102276. Epub 2017 Aug 23.
Comparing Outcomes of Genetic Counseling Options in Breast and Ovarian Cancer: An Integrative Review .
Fournier DM, Bazzell AF, Dains JE.Oncol Nurs Forum. 2018 Jan 1; 45(1):96-105.

See all (137)

This column displays citations for systematic reviews, meta-analyses, reviews of clinical trials, evidence-based medicine, consensus development conferences, and guidelines. See filter information or additional related sources.

Medical Genetics

Topic:

Results: 5 of 2754

Impact of an embedded genetic counselor on breast cancer treatment.
Pederson HJ, Hussain N, Noss R, Yanda C, O'Rourke C, Eng C, Grobmyer SR.Breast Cancer Res Treat. 2018 Jan 18; . Epub 2018 Jan 18.
Improving attendance to genetic counselling services for gynaecological oncology patients.
Pokharel HP, Hacker NF, Andrews L.Gynecol Oncol Res Pract. 2018; 5:2. Epub 2018 Jan 10.
Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study.
Copson ER, Maishman TC, Tapper WJ, Cutress RI, Greville-Heygate S, Altman DG, Eccles B, Gerty S, Durcan LT, Jones L, et al.Lancet Oncol. 2018 Jan 11; . Epub 2018 Jan 11.
Assessing the effectiveness of NICE criteria for stratifying breast cancer risk in a UK cohort.
Littlejohn LA, Gibbs J, Jordan LB, Miedzybrodzka ZH, Bell C, Goudie D, Dunlop J, Berg JN.Eur J Hum Genet. 2018 Jan 15; . Epub 2018 Jan 15.
The association between smoking and cancer incidence in BRCA1 and BRCA2 mutation carriers.
Ko KP, Kim SJ, Huzarski T, Gronwald J, Lubinski J, Lynch HT, Armel S, Park SK, Karlan B, Singer CF, et al.Int J Cancer. 2018 Jan 13; . Epub 2018 Jan 13.